NDC 43598-458

sorafenib

Sorafenib

sorafenib is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Dr.reddys Laboratories Inc. The primary component is Sorafenib Tosylate.

Product ID43598-458_1f7e4c4b-683f-f606-5ff3-f361f1be4ad0
NDC43598-458
Product TypeHuman Prescription Drug
Proprietary Namesorafenib
Generic NameSorafenib
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-06-08
Marketing CategoryANDA /
Application NumberANDA216073
Labeler NameDr.Reddys Laboratories Inc
Substance NameSORAFENIB TOSYLATE
Active Ingredient Strength200 mg/1
Pharm ClassesKinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 43598-458-04

120 TABLET, FILM COATED in 1 BOTTLE (43598-458-04)
Marketing Start Date2022-06-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "sorafenib" or generic name "Sorafenib"

NDCBrand NameGeneric Name
0480-5425SorafenibSorafenib
24979-715SorafenibSorafenib
43598-458sorafenibsorafenib
51990-201SorafenibSorafenib
50419-488Nexavarsorafenib
0378-1201Sorafenib TosylateSorafenib

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.